{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:36:57Z","timestamp":1776627417180,"version":"3.51.2"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Prostate Cancer (PCa) affects the population worldwide on a large scale in men. This paper\npresents a comprehensive overview of the evolving therapeutic landscape for PCa and highlights\nthe promise and challenges of gene- and cell-based strategies. There are various limitations to\nconventional modalities, such as radiotherapy, chemotherapy, and surgery; however, the growing\nimpact of molecular precision, immunotherapies, and innovative gene-editing tools, such as the\nclustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) system, minimizes\nthe limitations of these conventional therapies. Comparisons of the current progress in Oncolytic\nVirus (OV) based therapies, viral and non-viral gene delivery systems, and cell-based immunotherapies\nincluding Chimeric Antigen Receptor (CAR) T cells and Dendritic Cell (DC) therapies\ndemonstrate both their therapeutic potentials and key challenges to their effectiveness that include\nTumor Heterogeneity (TH), immune evasion, and the immunosuppressive Tumor Microenvironment\n(TME). The combination approach integrates the control point blockade, radiosensitizing\nchemotherapeutics, and biomarker-guided interventions to improve treatment outcomes. It also provides\na perspective for analyzing the future roles of Artificial Intelligence (AI), multi-omics integration,\nand collaborative research networks in shaping standards that are more personalized to enhance\ncare for PCa patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115665232479483260416092641","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T18:39:39Z","timestamp":1776623979000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shaping the Future of Prostate Cancer Care: The Promise and Pitfalls of Gene- and Cell-Based Therapeutics"],"prefix":"10.2174","volume":"26","author":[{"given":"Dherya","family":"Guleria","sequence":"first","affiliation":[{"name":"Department of Quality Assurance, ISF College of Pharmacy, Moga-142001, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6295-1798","authenticated-orcid":true,"given":"Navjot Kaur","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Department of Quality Assurance, ISF College of Pharmacy, Moga-142001, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665232479483260416092641","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/252625\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665232479483260416092641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T18:39:42Z","timestamp":1776623982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/252625\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115665232479483260416092641","relation":{},"ISSN":["1566-5232"],"issn-type":[{"value":"1566-5232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}